scPharmaceuticals Inc.

SCPH · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$18,024-$19,742-$18,845-$35,105
Dep. & Amort.$64$63$4-$87
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,519$1,295$1,285$1,226
Change in WC-$2,498-$224$164-$4,313
Other Non-Cash$2,828$1,469$2,206$20,855
Operating Cash Flow-$16,111-$17,139-$15,186-$17,424
Investing Activities
PP&E Inv.$0$0-$12-$9
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$12-$9
Financing Activities
Debt Repay.$0-$972$0-$4,228
Stock Issued$316$0$171$53,547
Stock Repurch.$0$0$0-$5,544,860
Dividends Paid$0$0$0$0
Other Fin. Act.-$624$0$52,916$21,094
Financing Cash Flow-$624-$972-$631$70,413
Forex Effect$0$0$0$0
Net Chg. in Cash-$16,735-$18,111-$15,829$52,980
Supplemental Information
Beg. Cash$57,544$75,655$91,484$38,504
End Cash$40,809$57,544$75,655$91,484
Free Cash Flow-$16,111-$17,139-$15,198-$17,433